Skip to content

Vitamin D deficiency increases risk of type 2 diabetes for patients with HIV

Nevirapine rather than efavirenz-based HIV treatment more likely to suppress viral load to zero

Bristol-Myers Squibb buys festinavir, new NRTI active against MDR HIV

Prompt treatment and better screening could prevent many cancer deaths in patients taking HIV therapy

Once-daily darunavir approved for some treatment-experienced patients in US

High triglycerides increase risk of neuropathy for patients with HIV

Tenofovir with 3TC or FTC associated with lower lipid increases than other NRTI pairs

Stem cell transplant has cured HIV infection in 'Berlin patient', say doctors

Timothy Ray Brown gave an interview to German magazine Stern.

Missed appointments in first six months of HIV treatment associated with poorer outcomes